Literature DB >> 846048

A clinicopathological study on cardiac lesions in 64 cases of disseminated intravascular coagulation.

M Sugiura, K Hiraoka, S Ohkawa, K Ueda, T Matsuda.   

Abstract

Diagnosis of disseminated intravascular coagulation (DIC) was made in 64 cases (16.2%) among a total of 395 autopsy cases. There were 31 men and 33 women. Their ages ranged from 31 to 91 years (mean 76.3). Underlying diseases were mainly malignancy and sepsis. Fresh cardiac lesions were found in 40 cases (62.5%). Coronary thrombosis was found in 13 cases (20.3%) and myocardial necrosis in 24 cases (37.5%), with acute myocardial infarction in 9 and focal necrosis in 15. Nonbacterial thrombotic endocarditis was found in 17 cases (26.6%), mural thrombi in 11 (17.2%), and bleeding of the heart in 11 (17.2%). Platelet count, fibrinogen and euglobulin lysis time were not correlated with myocardial necrosis nor coronary thrombosis. Increase of fibrin degradation products correlated with the presence of coronary thrombosis with or without myocardial necrosis. DIC was found with a high incidence in the aged, and many of them were complicated with fresh cardiac lesions. Development of acute myocardial infarction depends on the small thrombi in the severe stenosis of the main coronary arteries or on the multiple microthrombi in the peripheral coronary branches.

Entities:  

Mesh:

Year:  1977        PMID: 846048     DOI: 10.1536/ihj.18.57

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  11 in total

Review 1.  Thrombosis in COVID-19.

Authors:  Thomas C Hanff; Amir M Mohareb; Jay Giri; Jordana B Cohen; Julio A Chirinos
Journal:  Am J Hematol       Date:  2020-09-16       Impact factor: 10.047

2.  Immunohistochemical study on the liver in autopsy cases with disseminated intravascular coagulation (DIC) with reference to clinicopathological analysis.

Authors:  Y Esaki; K Hirokawa; T Fukazawa; T Matsuda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

3.  Report of a case with fulminant hepatitis A associated with acute renal failure.

Authors:  K Mizuiri; M Kameyama; Y Sagawa; T Yoshioka; T Hatori; T Nanba
Journal:  Gastroenterol Jpn       Date:  1985-10

Review 4.  Disseminated intravascular coagulation with congestive heart failure and left ventricular thrombus: a case report with literature review of 7 cases.

Authors:  Dmitri Belov; Radmila Lyubarova; Steven Fein; Mikhail Torosoff
Journal:  Am J Case Rep       Date:  2015-01-31

5.  Acute Coronary Syndrome Manifesting as an Adverse Effect of All-trans-Retinoic Acid in Acute Promyelocytic Leukemia: A Case Report with Review of the Literature and a Spotlight on Management.

Authors:  K Govind Babu; K N Lokesh; M C Suresh Babu; Gita R Bhat
Journal:  Case Rep Oncol Med       Date:  2016-02-11

Review 6.  Cardiovascular manifestations and treatment considerations in COVID-19.

Authors:  Yu Kang; Tiffany Chen; David Mui; Victor Ferrari; Dinesh Jagasia; Marielle Scherrer-Crosbie; Yucheng Chen; Yuchi Han
Journal:  Heart       Date:  2020-04-30       Impact factor: 5.994

Review 7.  Cardiovascular Manifestations of COVID-19 Infection.

Authors:  Ajit Magadum; Raj Kishore
Journal:  Cells       Date:  2020-11-19       Impact factor: 6.600

Review 8.  COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications.

Authors:  Matteo Cameli; Maria Concetta Pastore; Giulia Elena Mandoli; Flavio D'Ascenzi; Marta Focardi; Giulia Biagioni; Paolo Cameli; Giuseppe Patti; Federico Franchi; Sergio Mondillo; Serafina Valente
Journal:  Front Cardiovasc Med       Date:  2021-01-28

9.  Disseminated intravascular coagulation as a possible cause of acute coronary stent thrombosis: a case report and literature review.

Authors:  Syed Amer; Ali Shafiq; Waqas Qureshi; Mohammed Muqeetadnan; Syed Hassan
Journal:  Case Rep Crit Care       Date:  2012-12-17

Review 10.  Pathogenesis and management of myocardial injury in coronavirus disease 2019.

Authors:  Zhi-Yao Wei; Yong-Jian Geng; Ji Huang; Hai-Yan Qian
Journal:  Eur J Heart Fail       Date:  2020-08-22       Impact factor: 17.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.